Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease

Introduction: Adalimumab is effective in inducing and maintaining remission in children with inflammatory bowel diseases (IBD). Therapeutic drug monitoring is an important strategy to maximize the response rates, but data on the association of serum adalimumab levels are lacking. This study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucafò, Marianna, Curci, Debora, Bramuzzo, Matteo, Alvisi, Patrizia, Martelossi, Stefano, Silvestri, Tania, Guastalla, Veronica, Labriola, Flavio, Stocco, Gabriele, Decorti, Giuliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129012/
https://www.ncbi.nlm.nih.gov/pubmed/34017806
http://dx.doi.org/10.3389/fped.2021.646671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129012/
https://www.ncbi.nlm.nih.gov/pubmed/34017806
http://dx.doi.org/10.3389/fped.2021.646671

Ejemplares similares